Comments
Loading...
Cardiol Therapeutics (NASDAQ:CRDL) Stock, Earnings Estimates, EPS, And Revenue
Cardiol Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 31
EPS Estimate
$-0.080
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Cardiol Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Cardiol Therapeutics (CRDL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-0.13 | $-0.09 | -44.4 % |
| Q2 | 2024-08-12 | $-0.07 | $-0.09 | 18.9 % |
| Q1 | 2024-05-14 | $-0.10 | $-0.10 | 0.00 % |
| Q4 | 2024-04-01 | $-0.09 | $-0.12 | 25.0 % |
Cardiol Therapeutics (CRDL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Cardiol Therapeutics (NASDAQ:CRDL) reporting earnings?
Cardiol Therapeutics (CRDL) is scheduled to report earnings on March 31, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Cardiol Therapeutics (NASDAQ:CRDL)?
The Actual EPS was $-0.13, which missed the estimate of $-0.09.
What were Cardiol Therapeutics’s (NASDAQ:CRDL) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.